Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-15

FDA Approved: TAZAROTENE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved Padagis Israel Pharmaceuticals Ltd's Original Application for Tazarotene, establishing a generic topical retinoid. The product is intended for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

ORIG AP for TAZAROTENE (TAZAROTENE)